Thursday, 30 May 2024

 

 

LATEST NEWS Sukhbir Singh Badal Headed a massive road show in the holy city which broke all previous records Anurag Thakur exhorts people to vote for BJP for strong leadership, stable governance & foolproof national security Modi has brought Ram to Ayodhya now it is our duty to bring back Modi: Manoj Tiwari Two independent candidates extend support to Tandon Yuva Morcha holds protest on Swati Maliwal case Tandon gets big boost as Sehajdhari Sikhs to support BJP in Chandigarh and Himachal Pradesh Achhe din aane wale hain, Modi ji jane wale hain: Arvind Kejriwal in Chandigarh BJP’s formidable election machine is set to sweep aside Tewari on June 1: Sanjay Tandon Surveys are here, people have decided, AAP is winning by 13-0: Bhagwant Mann People of Punjab will reply to Amit Shah's threat on June 1, will get BJP's security deposits forfeited : Arvind Kejriwal For the first time, in the AAP govt youth is getting govt jobs in Punjab without any recommendation and bribe : Arvind Kejriwal When the people of Punjab did not bow down to Nadir Shah, then who is Amit Shah: Sanjay Singh Won’t let the peace of Punjab be disturbed at any cost : Sukhbir Singh Badal Rahul Gandhi announces loan waiver for farmers; legal guarantee on MSP Congress will not bring back good days but the old days : Gurjeet Singh Aujla Gurjeet Singh Aujla remembers Sidhu Moosewala Sidhu Moosewala Would have been with us if Punjab Govt. Controlled Crime : Vijay Inder Singla Warring gets further boost; BJP runner up from Ludhiana South Satha joins Congress Preparations for the Lok Sabha elections are complete, Voter are invited to participate in the festival of democracy on June 1 with enthusiasm - Deputy Commissioner Akali Dal chief, secretary and BC wing president join Congress Mann's appeal to the people of Anandpur Sahib: Now instead of swords, we are fighting against injustice and oppression with our votes, support us

 

DRDO nod for Mankind Pharma to make, market anti-Covid drug 2-DG

Delta Plus Covid variant, Delta Covid-19 variant, Coronavirus, COVID 19, Novel Coronavirus, Fight Against Corona, Covaxin, Covishield, Covid-19 Vaccine, Oxygen, Oxygen Cylinders, SARS-CoV-2, Sputnik V, Oxygen Plants, Pfizer, Astra Zeneca, Oxygen Concentrator, Defence Research and Development Organisation, DRDO, Mankind Pharma
Listen to this article

Web Admin

Web Admin

5 Dariya News

New Delhi , 08 Jul 2021

The Defence Research and Development Organisation (DRDO) has given Mankind Pharma the license to manufacture and market the oral 2-deoxy-D-glucose (2-DG) for the treatment of Covid-19, the pharmaceutical company said on Thursday.Mankind Pharma will absorb the technology and manufacture the product at its manufacturing facilities located at Andhra Pradesh's Vizag and Himachal Pradesh.2-DG has been touted as a game-changer in the battle against pandemic as it helps in faster recovery of hospitalised patients and reduces oxygen dependence in Covid-19 patients.In May, the Drugs Controller General of India (DGCI) approved 2-DG -- developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS) -- for emergency use in moderate to severe Covid-19 patients."Our objective behind this agreement is to ensure maximum reach of this medication to the deserving Indian patients suffering from the deadly pandemic. It is highly important that the Indian patients get such medicines easily and there is no shortage of such lifesaving drugs in the country. With this cause, we have partnered with DRDO to ramp up the manufacturing facilities and distribute the drug widely across India," Mankind Pharma said in a statement.Being a generic molecule and analogue of glucose, it can be easily produced and made available in plenty in the country.The drug comes in powder form in a sachet, which is taken orally by dissolving it in water.It accumulates in the virus infected cells and prevents virus growth by stopping viral synthesis and energy production. Its selective accumulation in virally infected cells makes this drug unique.Moreover, in clinical trials the patients treated with 2-DG showed faster symptomatic cure than Standard of Care (SoC) on various endpoints.

 

Tags: Delta Plus Covid variant , Delta Covid-19 variant , Coronavirus , COVID 19 , Novel Coronavirus , Fight Against Corona , Covaxin , Covishield , Covid-19 Vaccine , Oxygen , Oxygen Cylinders , SARS-CoV-2 , Sputnik V , Oxygen Plants , Pfizer , Astra Zeneca , Oxygen Concentrator , Defence Research and Development Organisation , DRDO , Mankind Pharma

 

 

related news

 

 

 

Photo Gallery

 

 

Video Gallery

 

 

5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2024 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD